Experimental models of hepatocellular carcinoma: developments and evolution

被引:0
|
作者
Long Wu
Zhao-You Tang
Yan Li
机构
[1] Zhongnan Hospital of Wuhan University and Hubei Key Laboratory of Tumour Biological Behaviors,Department of Oncology
[2] Shanghai Medical College of Fudan University,Liver Cancer Institute
[3] Renmin Hospital of Wuhan University,Department of Surgery
关键词
Hepatocellular carcinoma; Liver cancer; Experimental models;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The biological mechanisms of hepatocarcinogenesis and progression are poorly understood. Experimental models of HCC provide valuable tools to evaluate the risk factors, new treatment modalities and biologic characteristics. Under the constant evolution in model design and technology development, new experimental models continue to emerge, including spontaneous models, induced models, viral models, transplantable models, and genetically engineered models. These models are used as tools to investigate basic biological mechanisms of growth and differentiation, oncogene function, and as systems to test new diagnostic and therapeutic approaches. Each model has its own advantages and disadvantages. The progress in HCC model construction and studies are summarized in this review.
引用
收藏
页码:969 / 981
页数:12
相关论文
共 50 条
  • [21] New Developments in Systemic Therapy for Hepatocellular Carcinoma
    Dourakis, Spyros P.
    CURRENT CANCER THERAPY REVIEWS, 2008, 4 (03) : 219 - 226
  • [22] Latest developments in precancerous lesions of hepatocellular carcinoma
    Zhao-Shan Niu
    Xiao-Jun Niu
    Wen-Hong Wang
    Jing Zhao
    World Journal of Gastroenterology, 2016, 22 (12) : 3305 - 3314
  • [23] New developments in systemic therapy for hepatocellular carcinoma
    Dourakis, S. P.
    ANNALS OF GASTROENTEROLOGY, 2008, 21 (02): : 83 - 87
  • [24] Transarterial chemoembolization for hepatocellular carcinoma - new developments
    Kuhl, C.
    GASTROENTEROLOGE, 2009, 4 (04): : 330 - 339
  • [25] Developments in predictive biomarkers for hepatocellular carcinoma therapy
    Andrea, Casadei-Gardini
    Giulia, Orsi
    Francesco, Caputo
    Giorgio, Ercolani
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (01) : 63 - 74
  • [26] Latest developments in targeted therapy for hepatocellular carcinoma
    Montella, Liliana
    Addeo, Raffaele
    Caraglia, Michele
    Del Prete, Salvatore
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (10) : 1635 - 1646
  • [27] Latest developments in precancerous lesions of hepatocellular carcinoma
    Niu, Zhao-Shan
    Niu, Xiao-Jun
    Wang, Wen-Hong
    Zhao, Jing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (12) : 3305 - 3314
  • [28] Animal models for hepatocellular carcinoma
    Zhang, Hui Emma
    Henderson, James M.
    Gorrell, Mark D.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (05): : 993 - 1002
  • [29] Mouse Models of Hepatocellular Carcinoma
    Fausto, Nelson
    Campbell, Jean S.
    SEMINARS IN LIVER DISEASE, 2010, 30 (01) : 87 - 98
  • [30] Precision models in hepatocellular carcinoma
    Barcena-Varela, Marina
    Monga, Satdarshan P.
    Lujambio, Amaia
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2025, 22 (03) : 191 - 205